Leukemia & Lymphoma Society Translational Research Program
Application Deadline: Oct. 31, 2019; required letter of intent Aug. 31, 2019
LLS Translational Research Program was developed to encourage and provide early support for clinical research in leukemia, lymphoma, and myeloma focused on innovative approaches to treatment, diagnosis, and prevention. The program is designed to support new and innovative research that demonstrates high promise for translating basic biomedical knowledge to clinical application. Projects should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.
More details here.

CTSI Translational Accelerator Funding Agreements
Application Deadline: Sept. 5, 2019; Optional Letter of Intent due: Aug. 20, 2019
Support for cross-disciplinary scientific research addressing the development of therapies diagnostics, or devices applicable to human disease, clinical research trials (excluding Phase 2 and beyond), epidemiological studies, and/or community-based research. Up to $150,000.
More information and application details

CTSI Transformative Funding Agreements
Application Deadline: Sept. 5, 2019; Optional Letter of Intent due: Aug. 20, 2019
Supporting the development of mature research with the potential to attract significant interest for external partnering, thus enabling and accelerating translation of research out of the academic environment. Up to $500,000.
More information and application details